• 22/04/2024

    Shorter DR-TB treatment regimens and cardiac monitoring

    Cardiac monitoring for people on novel short DR-TB treatment regimens can be decentralized and accessible. Dealing…

    Lees meer
  • 15/04/2024

    Private sector TB care can better capacity for primary treatment

    With the right incentives and administrative backing, informal healthcare providers and pharmacists can become partners in the country’s public health…

    Lees meer
  • 24/03/2024

    Meet the new TB ambassador for KNCV: Paulina Siniatkina

    Today, on World TB Day, we would like to proudly announce that Paulina Siniatkina will become a TB ambassador for…

    Lees meer
  • 24/03/2024

    Welcome to the KNCV family!

    We acknowledge that impactful work is not done in isolation, and requires different sets of expertise and local knowledge. On…

    Lees meer
  • 24/03/2024

    Digital Adherence Webinar Invitation

    In alignment with of our collective actions towards ending TB, KNCV standing as the…

    Lees meer
  • 05/02/2024

    Call for Application: Web-based application and database consultation service

    KNCV TB Plus is looking for a: Web-based application and database (developer and maintenance) consultation service Background KNCV TB Plus…

    Lees meer
  • 15/01/2024

    Global Fund Approves US$9.2 Billion in New Grants to Accelerate Fight Against HIV, TB and Malaria in More than 70 Countries

    The Global Fund to Fight AIDS, Tuberculosis and Malaria has approved US$9.2 billion for grants…

    Lees meer
  • 12/01/2024

    Changing of the guards at KNCV Board of Trustees

    KNCV’s Board of Trustees is delighted to welcome Dr. Zemzem Shigute Shuka, appointed by the KNCV General Assembly to the…

    Lees meer
  • 19/12/2023

    Request for Quotation to supply 1 motor vehicle to KNCV Tuberculosis Foundation

    REFERENCE NO. – KNCVI-PVEH-P/23/23-1  General Information:               KNCV is inviting vendors to provide quotations for the supply of 1 motor vehicle.

    Lees meer
  • 11/12/2023

    New child-friendly formulation of rifapentine for short course tuberculosis prevention treatment

    More than 2 million children and adolescents lack preventive treatment for TB, which is needed for those living…

    Lees meer
  • 11/12/2023

    Request for Proposals: Market interventions for critical tools needed for drug-resistant TB care

    This Request for Proposals (RfP) is issued by the Tuberculosis Foundation (KNCV) and Unitaid in…

    Lees meer
  • 29/11/2023

    Celebrating 120 years KNCV at the Union World Conference 2023

    The first Union World Conference in person since the COVID-19 pandemic was held in Paris from November 15-18 and was…

    Lees meer
  • 21/11/2023

    Begimay survived MDR-TB and uses her experience to fight TB

    Begimay is a young mother of three children who recovered from multi-drug resistant tuberculosis (MDR-TB). Her difficult and long battle…

    Lees meer
  • 16/11/2023

    KNCV’s ‘No more pandemics’ project empowers Kyrgyzstan and Tanzania in the fight against TB and other infectious diseases

    Ineke Spruijt, Consultant and Epidemiologist, and Norma Madden, Monitor and Evaluation Officer, from KNCV’s global office in the Netherlands…

    Lees meer
  • 08/11/2023

    ‘Rich Heritage, Bright Future’: Celebrating 120 years of KNCV

    On Monday, November 6, KNCV Tuberculosis Foundation celebrated its 120th anniversary in the Naturalis Museum in Leiden,…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us


De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.